To add to HemaXellerate valuation speculation He
Post# of 5066
Posted On: 12/19/2015 4:01:46 PM
To add to HemaXellerate valuation speculation
http://www.prnewswire.com/news-releases/regen...16148.html
Quote:
HemaXellerate is a personalized stem cell therapy that stimulates production of blood cells from the bone marrow of patients. Regen is planning to utilize HemaXellerate to treat patients with aplastic anemia, a condition associated with reduced ability of the bone marrow to make blood. The Company's CEO also stated, "If successful, the Company may expand into other conditions such as poor blood production associated with chemotherapy which is a potential multibillion dollar per year market."
http://www.prnewswire.com/news-releases/regen...16148.html
(0)
(0)